Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.46 USD | +4.33% | -5.04% | -23.49% |
May. 09 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
May. 08 | Pharvaris N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Pharvaris N.V.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Pharvaris N.V.
Wedbush | |
Morgan Stanley | |
JMP Securities | |
Oppenheimer | |
SVB Securities LLC | |
BofA Securities | |
SVB Leerink |
EPS Revisions
- Stock Market
- Equities
- PHVS Stock
- Consensus Pharvaris N.V.